Search results
Order by most recent / most popular / relevance
Results: 1-10 of 25
NASDAQ Biotechnology Index surpasses all-time high in 1Q13
- Shook Hardy & Bacon LLP
- -
- USA
- -
- May 16 2013
The NASDAQ Biotechnology Index reportedly rose in the first quarter of 2013 (1Q13) above levels last seen during the 2000 genomics bubble peakthe
New program to provide accelerated “speed-to-market” for medical device entrepreneurs
- Shook Hardy & Bacon LLP
- -
- USA
- -
- March 1 2012
The nonprofit Memphis Bioworks Foundation and Innova, a pre-seed, seed and early-stage investor, have announced a program designed to help entrepreneurs bring medical device products and companies to market
Cincinnati investor closes $4.4 million fund to invest in startups
- Shook Hardy & Bacon LLP
- -
- USA
- -
- June 30 2011
Cincinnati-based CincyTech, a venture development company that invests in startup biotech, information technology and advanced manufacturing businesses, has announced the closing of a $4.4 million Fund II targeted for 10 to 12 new startups in southwest Ohio
Biotech investments rise in Q4 2012, but remain off for the year
- Shook Hardy & Bacon LLP
- -
- USA
- -
- January 24 2013
Pricewatershouse Coopers LLP has released its fourth quarter (Q4) and final 2012 venture capital investment reports and notes that "Biotechnology
Agilent Technologies acquires BIOCIUS Life Sciences
- Shook Hardy & Bacon LLP
- -
- USA
- -
- March 10 2011
California-based Agilent Technologies has announced the acquisition of BIOCIUS Life Sciences, a Massachusetts-based company that developed a spectrometry device, enabling "researchers to gain a fuller understanding of a drug's biochemical properties, including potential liabilities in drug interactions
Medicinova and Zhejiang Medicine announce joint venture in China
- Shook Hardy & Bacon LLP
- -
- China, USA
- -
- March 10 2011
California-based biopharmaceutical company MediciNova Inc. and Zhejiang Medicine Co., a Chinese pharmaceutical manufacturer, have announced a joint venture to develop and commercialize MediciNova’s MN-221 in China
Court upholds drug profit sharing; pharma co. breached agreement to negotiate deal
- Shook Hardy & Bacon LLP
- -
- USA
- -
- June 7 2012
A Delaware court has issued a letter opinion finalizing its 2011 ruling requiring SIGA Technologies Inc. to share profits from its smallpox drug with PharmAthene, Inc. PharmAthene, Inc. v. SIGA Techs, Inc., No. 267-VCP (Del. Ch., decided May 31, 2012
Israeli biotechnology startups seek partnerships in Ohio
- Shook Hardy & Bacon LLP
- -
- USA
- -
- December 16 2010
Israeli biotechnology companies are reportedly heading to Ohio because of state incentives and a venture capital fund focused on investing in Israel
Pharma merger activity attributed to “patent cliff”
- Shook Hardy & Bacon LLP
- -
- USA
- -
- November 18 2010
Noting that many of the pharmaceutical industry's best-selling products will soon lose their patent protection, industry analysts have reportedly suggested that the potential loss of nearly one-third of industry revenues in the near term could account for recent merger activity among the world's largest pharmaceutical companies
Fewer small biotech companies go public
- Shook Hardy & Bacon LLP
- -
- USA
- -
- March 10 2011
Smaller biotechnology companies maneuvering through drug-development regulations are reportedly focusing their efforts on licensing products in development or selling their businesses to large pharmaceutical companies rather than pursuing an initial public offering (IPO
Current Search
- Author - Madeleine McDonough
- Firm Name - Shook Hardy & Bacon LLP
- Jurisdiction - USA
- Workarea - Corporate Finance/M&A
- Workarea - Healthcare
Suggested Facets
Author
- Chris A. Johnson (11)
- Debra S. Dunne (1)
- John D. Garretson (7)
- Patrick Henderson (25)
- Thomas T. Moga (25)